Lyell Immunopharma
LYEL
LYEL
62 hedge funds and large institutions have $1.22B invested in Lyell Immunopharma in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 18 closing their positions.
Holders
62
Holders Change
+10
Holders Change %
+19.23%
% of All Funds
1.09%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.11%
New
28
Increased
11
Reduced
11
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$21.1M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$54.2M |
| 3 |
HH
3
HSG Holding
Na,
Hong Kong
|
$45.1M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$32.7M |
| 5 |
5
Brown Advisory
Baltimore,
Maryland
|
$6.76M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MS
76
Maven Securities
St Helier,
Jersey
| – | – | -12,195 | Closed |
|
77
Tudor Investment Corp
Stamford,
Connecticut
| – | – | -11,954 | Closed |
|
|
RCM
78
Rokos Capital Management
London,
United Kingdom
| – | – | -5,000 | Closed |
|
|
KAM
79
Kirkoswald Asset Management
New York
| – | – | -1,000 | Closed |
|
|
WCMNY
80
Westchester Capital Management (New York)
Valhalla,
New York
| – | – | -500 | Closed |
|
|
CFGS
81
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|